Fair Value Measurement of Assets and Liabilities - Additional Information (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Business combination contingent consideration payments | $ 17.4 | $ 1.5 |
| Common Stock [Member] | Embody, Inc. | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Issuance of common stock for contingent consideration liability | 0.3 | |
| Issuance of common stock for contingent consideration liability, valued | $ 27.8 | |
| Business combination contingent consideration payments | $ 4.4 | |
| Fair value of common stock at the settlement date | $ 101.02 | |